Detalles de la búsqueda
1.
Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer.
Clin Infect Dis
; 36(1): 116-9, 2003 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12491212
2.
Risk classification at the time of diagnosis differentially affects the level of residual disease in children with B-precursor acute lymphoblastic leukemia after completion of therapy.
Leuk Res
; 27(8): 743-50, 2003 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12801533
3.
Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941).
Pediatr Blood Cancer
; 47(2): 141-6, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16425271
4.
Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
J Clin Oncol
; 24(19): 3150-6, 2006 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16717292
5.
Molecular monitoring of cerebrospinal fluid can predict clinical relapse in acute lymphoblastic leukemia with eosinophilia.
Arch Pathol Lab Med
; 127(5): 601-5, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12708906
6.
Residual leukaemia after bone marrow transplant in children with acute lymphoblastic leukaemia after first haematological relapse or with poor initial presenting features.
Br J Haematol
; 120(4): 711-5, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12588362
Resultados
1 -
6
de 6
1
Próxima >
>>